US Prescription trends of antihistamines for atopic dermatitis, 2011-2016

Swati Garg, Jeffrey Zhao, Kyle Tegtmeyer, Parth Shah, Peter A. Lio*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Antihistamine use for primary treatment of atopic dermatitis (AD) is not recommended, but current guidelines state that sedating antihistamines are favored over non-sedating antihistamines for relief of burdensome pruritus. We analyzed the National Ambulatory Medical Care Survey data to compare use of antihistamines between dermatologists and non-dermatologists. Overall, dermatologists are more likely to prescribe sedating than non-sedating antihistamines when compared to non-dermatologists (P <.001, δabs = 0.45). Patients under 21 years old (P =.03, δabs = 0.10) and Black patients (P <.001, δabs = 0.19) were also more likely to receive sedating antihistamines than non-sedating antihistamines. These findings highlight the differential prescribing practices for atopic dermatitis among physicians.

Original languageEnglish (US)
Pages (from-to)324-326
Number of pages3
JournalPediatric dermatology
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2021

Keywords

  • AAD
  • NAMCS
  • antihistamine
  • atopic dermatitis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Fingerprint

Dive into the research topics of 'US Prescription trends of antihistamines for atopic dermatitis, 2011-2016'. Together they form a unique fingerprint.

Cite this